Every story in this section, newest first — page 368 of 373.
Steel Dynamics (NASDAQ:STLD) has provided its earnings guidance for the fourth quarter of fiscal year 2025, forecasting a range of $1.65 to $1.69 per diluted share.
This represents a notable decline from the $2.74 per share earnings reported in the third quarter of 2025, but an increase over the $1.36 per share reported in Q4 2024.
Coursera (NYSE:COUR) and Udemy (NASDAQ:UDMY) announced today that they have entered into a definitive merger agreement to combine in an all-stock transaction valued at approximately $2.5 billion.
Wiley (NYSE:WLY), a global leader in scientific content and research intelligence, has announced a quarterly cash dividend of $0.355 per share, effective January 15, 2026.
Nucor (NYSE:NUE) has provided its earnings guidance for the fourth quarter of fiscal year 2025, forecasting earnings per share (EPS) in the range of $1.65 to $1.75.
Jabil (NYSE:JBL) has reported preliminary, unaudited financial results for the first quarter of fiscal year 2026, posting strong performance with net revenue of $8.3 billion.
The company's U.S. GAAP operating income stood at $283 million, and U.S. GAAP diluted earnings per share (EPS) was $1.35.
Texas Pacific Land Corporation (NYSE:TPL) has announced a strategic partnership with Bolt Data & Energy (Bolt) to develop large-scale data center campuses and the necessary infrastructure across TPL land.
Warner Bros. Discovery (NASDAQ:WBD) has announced that its Board of Directors has unanimously rejected the tender offer launched by Paramount Skydance (NASDAQ:PSKY) on December 8, 2025.
ABM (NYSE:ABM) has announced its agreement to acquire WGNSTAR in a cash transaction valued at approximately $275 million.
Sealed Air (NYSE:SEE) announced the expiration of the 30-day go-shop period under its definitive merger agreement with funds affiliated with Clayton, Dubilier & Rice (CD&R) on December 16, 2025.
Merck (NYSE:MRK) announced positive topline results from the Phase 3 KEYNOTE-B15 trial (also known as EV-304) in patients with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin-based chemotherapy.
Pfizer (NYSE:PFE) and Astellas have announced positive topline results from the interim analysis of the Phase 3 EV-304 (KEYNOTE-B15) trial, evaluating the combination of PADCEV (enfortumab vedotin) and Keytruda (pembrolizumab) in cisplatin-eligible patients with muscle-invasive bladder cancer (MIBC).
Sinclair (NASDAQ:SBGI) issued a statement today in response to The E.W. Scripps Company (NASDAQ:SSP) rejecting its proposal for a potential merger.
Veru (NASDAQ:VERU) announced its fiscal 2025 results and provided updates on its clinical development of enobosarm for obesity treatment on December 17, 2025.
Wallbox (NYSE:WBX), a global leader in electric vehicle (EV) charging and energy management solutions, announced the appointment of Isabel López Trujillo as Chief Financial Officer (CFO), effective January 7, 2026.
Hut 8 (NASDAQ:HUT) has announced a strategic partnership with Anthropic and Fluidstack to build hyperscale AI data center infrastructure in the U.S., with an initial deployment of 245 MW at River Bend.
China Automotive Systems (NASDAQ:CAAS) announced that its subsidiary, Hubei Henglong, has won a contract to supply its column-assist electric power steering (C-EPS) system for a new South American vehicle platform.
Four Corners Property Trust (NYSE:FCPT) announced the acquisition of four Mission Pet Health properties for $9.3 million, further expanding its portfolio of high-quality, net-leased restaurant and retail assets.
Agnico Eagle (NYSE:AEM) has acquired 26 million common shares of Osisko Metals (C$0.48 per share) for a total of C$12,480,000 through a non-brokered private placement, announced on Dec. 16, 2025.
Mercantile Bank Corporation (NASDAQ:MBWM) and Eastern Michigan Financial Corporation announced on Dec. 16, 2025, that they have received approval from the Federal Reserve Bank of Chicago for their proposed merger.
President Donald Trump is set to interview Federal Reserve Governor Christopher Waller for the next Fed Chair role, as the White House weighs a potential shift in monetary policy and crypto stance.
GSK (NYSE:GSK) announced the U.S. Food and Drug Administration (FDA) approval of Exdensur (depemokimab), a novel, long-acting biologic treatment for severe asthma with an eosinophilic phenotype.
111 (NASDAQ:YI) today reported its third-quarter 2025 unaudited financial results, showcasing a strategic pivot towards an asset-light model to bolster cash flow and liquidity.
Diageo (NYSE:DEO) has reached an agreement to sell its 65% stake in East African Breweries (EABL) and its 53.68% share in UDVK to Japan’s Asahi Group for an estimated net gain of $2.3 billion after taxes and transaction costs.
